Cencora, Inc. $COR Stock: AIA Group Ltd Increases Position

Key Points

• AIA Group increased its Cencora stake by 1,344.8% in the third quarter, adding 14,241 shares to hold 15,300 shares worth about $4.6 million.
• Cencora reported quarterly EPS of $4.66 and revenue of $88.35 billion, beating analyst estimates; revenue rose 5.5% year over year.
• The company raised its quarterly dividend 10%, from $0.60 to $0.66 per share. Analysts’ consensus rating is “Moderate Buy,” with an average price target of $368.38.

AIA Group Ltd increased its position in shares of Cencora, Inc. (NYSE:COR - Free Report) by 1,344.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,300 shares of the company's stock after buying an additional 14,241 shares during the period. AIA Group Ltd's holdings in Cencora were worth $4,594,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Provenance Wealth Advisors LLC increased its holdings in Cencora by 24,393.8% in the third quarter. Provenance Wealth Advisors LLC now owns 3,919 shares of the company's stock valued at $1,177,000 after buying an additional 3,903 shares during the last quarter. TrinityBridge Ltd boosted its holdings in shares of Cencora by 35.8% during the third quarter. TrinityBridge Ltd now owns 145,444 shares of the company's stock valued at $43,692,000 after acquiring an additional 38,339 shares during the period. Integrity Alliance LLC. boosted its stake in Cencora by 4.6% during the 3rd quarter. Integrity Alliance LLC. now owns 5,497 shares of the company's stock valued at $1,651,000 after purchasing an additional 240 shares during the period. Integrity Advisory Solutions LLC bought a new position in Cencora in the 3rd quarter worth approximately $207,000. Finally, GRIMES & Co WEALTH MANAGEMENT LLC grew its holdings in Cencora by 3.7% in the 3rd quarter. GRIMES & Co WEALTH MANAGEMENT LLC now owns 1,313 shares of the company's stock worth $394,000 after buying an additional 47 shares in the last quarter. Hedge funds and other institutional investors own 97.52% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. UBS Group lowered their target price on Cencora from $430.00 to $400.00 and set a "buy" rating on the stock in a research report on Friday, October 16th. Morgan Stanley increased their price target on Cencora from $346.00 to $377.00 and gave the stock an "overweight" rating in a research note on Friday, October 30th. JPMorgan Chase & Co. raised their price target on Cencora from $382.00 to $390.00 and gave the company an "overweight" rating in a report on Friday, August 7th. Evercore restated an "outperform" rating and set a $350.00 price objective (up from $330.00) on shares of Cencora in a research note on Thursday, August 6th. Finally, Wall Street Zen raised shares of Cencora from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Fourteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $368.38.

Cencora Trading Up 4.0%

Shares of Cencora stock opened at $354.20 on Thursday. The business has a fifty day simple moving average of $324.60 and a 200-day simple moving average of $317.44. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The firm has a market cap of $67.59 billion, a price-to-earnings ratio of 26.31, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58. The company has a quick ratio of 0.58, a current ratio of 0.93 and a debt-to-equity ratio of 3.53.

Cencora (NYSE:COR - Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $4.66 EPS for the quarter, topping the consensus estimate of $4.58 by $0.08. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The firm had revenue of $88.35 billion for the quarter, compared to analysts' expectations of $87.95 billion. During the same period in the previous year, the business earned $3.84 earnings per share. Cencora's revenue for the quarter was up 5.5% compared to the same quarter last year. On average, equities analysts forecast that Cencora, Inc. will post 17.88 EPS for the current fiscal year.

Cencora Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be paid a dividend of $0.66 per share. This is a boost from Cencora's previous quarterly dividend of $0.60. This represents a $2.64 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, November 13th. Cencora's dividend payout ratio (DPR) is currently 17.83%.

Cencora News Roundup

Here are the key news stories impacting Cencora this week:

• Positive Sentiment: Fiscal Q4 adjusted EPS of $4.66 beat the $4.58 consensus, while revenue of $88.35 billion topped estimates of $87.95 billion and rose 5.5% year over year. Cencora also reported higher earnings than a year earlier. Article: Cencora Q4 Earnings & Revenues Beat on Specialty Growth, Margins Expand
• Positive Sentiment: The company forecast fiscal 2027 EPS of $19.40–$19.75, with specialty growth supporting its outlook. The guidance gives investors an indication of continued earnings growth. Article: Cencora outlines fiscal 2027 EPS outlook
• Positive Sentiment: Cencora raised its quarterly dividend 10%, from $0.60 to $0.66 per share, signaling increased cash returns to shareholders. Company dividend information
• Neutral Sentiment: Cencora is reorganizing its reporting structure to improve focus and visibility. The change may help execution, though the new structure itself does not establish a near-term financial benefit. Article: Cencora announces new organizational and reporting structure
• Neutral Sentiment: Management’s earnings-call discussion was broadly positive but included mention of headwinds; the provided coverage does not detail their size or likely effect on results. Article: Cencora earnings call highlights specialty growth and headwinds

Insiders Place Their Bets

In other Cencora news, EVP Elizabeth Campbell sold 11,300 shares of Cencora stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $324.12, for a total value of $3,662,556.00. Following the transaction, the executive vice president owned 19,455 shares in the company, valued at approximately $6,305,754.60. The trade was a 36.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.38% of the company's stock.

About Cencora

Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical sourcing and distribution company. It provides branded, generic and specialty pharmaceuticals, over-the-counter products and related health care supplies to pharmacies, hospitals, health systems, physician practices and other health care providers.

The company also offers services to pharmaceutical and biotechnology manufacturers, including logistics, commercialization support, market access, consulting, clinical trial support and patient assistance programs.

Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:COR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.